Device Trial Radar · NCT04658095
Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)
Last checked: Nov 19, 2026Latest source record: Oct 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
10
Actual
Start
Jan 11, 2022
Primary completion
Nov 18, 2022
Study completion Nov 18, 2022
Sponsor
- Lead sponsor
- Sight Sciences, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 8, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
First, to compare safety and effectiveness outcomes for canaloplasty and trabeculotomy using the OMNI Surgical System to implantation of the iStent inject in lowering intraocular pressure (IOP) in pseudophakic eyes with open angle glaucoma (OAG), and second, to compare safety and effectiveness outcomes for canaloplasty alone (using the OMNI Surgical System)to implantation of the iStent Inject in lowering IOP in pseudophakic eyes with OAG.
Conditions
- Glaucoma, Open-Angle
Interventions
Canaloplasty and trabeculotomy with the OMNI system.Device
Ab-interno canaloplasty (360 degrees) and up to 360 degrees trabeculotomy
iStent injectDevice
Ab-interno implantation of iStent inject (2 microstents)
CanaloplastyDevice
Ab-interno canaloplasty (360 degrees) using the OMNI
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change in Unmedicated DIOP From Baseline at the 12-month Postoperative ExaminationTime frame: 12 months
Locations
5 sites in 3 countries. Site status is shown where the registry gives one.
BurgerHospital
Frankfurt, Germany
Institut Catala de Retina (ICR)
Barcelona, Spain
Universidad Complutense de Madrid
Valencia, Spain
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.